Kemp Proteins will support upstream and downstream process optimization and manufacturing efforts for Avivo’s proprietary enzyme platform, which is designed to convert type A, B, and AB blood into universal donor type O blood.
June 2, 2026
June 2, 2026
Kemp Proteins will support upstream and downstream process optimization and manufacturing efforts for Avivo’s proprietary enzyme platform, which is designed to convert type A, B, and AB blood into universal donor type O blood.